Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bio-Thera SolutionsSHSE:688177 -4.78%61 Days Inventory is 655.50 as of Mar. 2026, which is 25% above its 10-year median of 523.31. GuruFocus rates SHSE:688177 with a GF Score™ of 61/100 and a GF Value™ of ¥35.93 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 640 Biotechnology companies, Bio-Thera Solutions ranks worse than 83.91% on this metric.
The historical rank and industry rank for Bio-Thera Solutions's Days Inventory or its related term are showing as below:
SHSE:688177'
s Days Inventory Range Over the Past 10 Years
Min: 241.26 Med: 523.31 Max: 114485.96
Current: 554.97
During the past 10 years, Bio-Thera Solutions's highest Days Inventory was 114485.96. The lowest was 241.26. And the median was 523.31.
SHSE:688177's Days Inventory is ranked worse than 83.91% of 640
companies
in the Biotechnology industry
Industry Median: 182.87
vs SHSE:688177: 554.97
Bio-Thera Solutions's Days Inventory
increased
from Mar. 2025 (493.17) to Mar. 2026 (655.50).
It might indicate that Bio-Thera Solutions's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Bio-Thera Solutions's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.14.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bio-Thera Solutions's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.34.
Bio-Thera Solutions (SHSE:688177) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Bio-Thera Solutions's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bio-Thera Solutions's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Bio-Thera Solutions Days Inventory Related Terms
Bio-Thera Solutions Days Inventory Historical Data
* Premium members only.
The historical data trend for Bio-Thera Solutions's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688177 vs VRTX, REGN, RVMD: Days Inventory Comparison
For the Biotechnology subindustry, Bio-Thera Solutions's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Thera Solutions Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bio-Thera Solutions's Days Inventory distribution charts can be found below:
* The bar in red indicates where Bio-Thera Solutions's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio-Thera Solutions (SHSE:688177) has a Days Inventory of 655.50 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bio-Thera Solutions and its competitors. This is 25% above median its historical median of 523.31. Over the past decade, Bio-Thera Solutions' Days Inventory has ranged from 241.26 to 114,485.96. According to the industry distribution chart, Bio-Thera Solutions ranks #537 out of 640 companies in the Biotechnology industry, placing it in the top 83.9%.
Is Bio-Thera Solutions' Days Inventory too high?
Bio-Thera Solutions' current Days Inventory of 655.50 is 25% above median its 10-year median of 523.31. Over the past 10 years, this metric has ranged from a low of 241.26 to a high of 114,485.96. The Biotechnology industry median Days Inventory is 182.87. Bio-Thera Solutions' value of 655.50 is 258.5% above this industry median. Based on the distribution chart, Bio-Thera Solutions ranks #537 out of 640 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Bio-Thera Solutions has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bio-Thera Solutions' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bio-Thera Solutions ranks #537 out of 640 companies for Days Inventory. This places Bio-Thera Solutions in the lower half of its industry. The industry median Days Inventory is 182.87. Bio-Thera Solutions' value of 655.50 is 258.5% above this benchmark. Historically, Bio-Thera Solutions' own Days Inventory has ranged from 241.26 to 114,485.96 over the past decade. While the company's 10-year median is 523.31 vs. the industry median of 182.87, Bio-Thera Solutions has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 182.87, based on 640 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bio-Thera Solutions's current Days Inventory of 655.50 is 258.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bio-Thera Solutions and its competitors. For the Biotechnology industry, the median Days Inventory is 182.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio-Thera Solutions's current Days Inventory is 655.50, which is 25% above median its own 10-year median of 523.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Thera Solutions stock overvalued right now?
Based on GuruFocus' analysis, Bio-Thera Solutions (SHSE:688177) is currently considered Possible Value Trap. The stock's GF Value™ is ¥35.93, compared to a current price of ¥20.71 — trading 42.4% below its estimated fair value. The current Days Inventory is 655.50, which is 25% above median its 10-year median of 523.31 and 258.5% above the Biotechnology industry median of 182.87. Bio-Thera Solutions' overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Bio-Thera Solutions (SHSE:688177), the current Days Inventory is 655.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bio-Thera Solutions (SHSE:688177) Overvalued in 2026?
Based on GuruFocus' analysis, Bio-Thera Solutions stock appears to be undervalued.
The current stock price of ¥20.71 is trading 42.4% below its estimated GF Value™ of ¥35.93.
GuruFocus considers Bio-Thera Solutions to be Possible Value Trap.
Key valuation signals for SHSE:688177:
Days Inventory: 655.50 (25% above median its 10-year median of 523.31)
GF Value™: ¥35.93 vs. price of ¥20.71 (42.4% below fair value)
Industry Position: 258.5% above the Biotechnology median (#537 of 640)
No single metric tells the full story. See the SHSE:688177 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bio-Thera Solutions Ltd is engaged in research, development, and production of drugs and biosimilars. The company provides drug research and development; biotechnology consulting and communication services; services; medical research and experimental development; biological drug manufacturing; and pharmaceuticals retail.
61GF Score
Get the complete analysis for SHSE:688177
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688177 has been successfully added to your 
